Logo image of 1FRE.MI

FRESENIUS SE & CO KGAA (1FRE.MI) Stock Fundamental Analysis

BIT:1FRE - Euronext Milan - DE0005785604 - Common Stock - Currency: EUR

40.89  -2.8 (-6.41%)

Fundamental Rating

4

Overall 1FRE gets a fundamental rating of 4 out of 10. We evaluated 1FRE against 25 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of 1FRE get a neutral evaluation. Nothing too spectacular is happening here. 1FRE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year 1FRE was profitable.
In the past year 1FRE had a positive cash flow from operations.
Of the past 5 years 1FRE 4 years were profitable.
Each year in the past 5 years 1FRE had a positive operating cash flow.
1FRE.MI Yearly Net Income VS EBIT VS OCF VS FCF1FRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

1FRE has a worse Return On Assets (0.98%) than 64.00% of its industry peers.
With a Return On Equity value of 2.17%, 1FRE is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
The Return On Invested Capital of 1FRE (4.04%) is comparable to the rest of the industry.
1FRE had an Average Return On Invested Capital over the past 3 years of 2.76%. This is below the industry average of 5.74%.
The last Return On Invested Capital (4.04%) for 1FRE is above the 3 year average (2.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROIC 4.04%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)2.76%
ROIC(5y)3.92%
1FRE.MI Yearly ROA, ROE, ROIC1FRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

1FRE has a Profit Margin (1.91%) which is comparable to the rest of the industry.
1FRE's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.68%, 1FRE belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
1FRE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 24.48%, 1FRE is in line with its industry, outperforming 52.00% of the companies in the same industry.
1FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
1FRE.MI Yearly Profit, Operating, Gross Margins1FRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1FRE is destroying value.
Compared to 1 year ago, 1FRE has about the same amount of shares outstanding.
Compared to 5 years ago, 1FRE has more shares outstanding
The debt/assets ratio for 1FRE has been reduced compared to a year ago.
1FRE.MI Yearly Shares Outstanding1FRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1FRE.MI Yearly Total Debt VS Total Assets1FRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1FRE has an Altman-Z score of 1.94. This is not the best score and indicates that 1FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.94, 1FRE is in line with its industry, outperforming 56.00% of the companies in the same industry.
1FRE has a debt to FCF ratio of 8.76. This is a slightly negative value and a sign of low solvency as 1FRE would need 8.76 years to pay back of all of its debts.
1FRE has a Debt to FCF ratio of 8.76. This is comparable to the rest of the industry: 1FRE outperforms 56.00% of its industry peers.
1FRE has a Debt/Equity ratio of 0.62. This is a neutral value indicating 1FRE is somewhat dependend on debt financing.
1FRE has a Debt to Equity ratio of 0.62. This is in the better half of the industry: 1FRE outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Altman-Z 1.94
ROIC/WACC0.78
WACC5.21%
1FRE.MI Yearly LT Debt VS Equity VS FCF1FRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

1FRE has a Current Ratio of 1.43. This is a normal value and indicates that 1FRE is financially healthy and should not expect problems in meeting its short term obligations.
1FRE's Current ratio of 1.43 is fine compared to the rest of the industry. 1FRE outperforms 68.00% of its industry peers.
A Quick Ratio of 1.11 indicates that 1FRE should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.11, 1FRE is doing good in the industry, outperforming 76.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.11
1FRE.MI Yearly Current Assets VS Current Liabilites1FRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 785.11% over the past year.
Measured over the past years, 1FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
The Revenue for 1FRE has decreased by -20.12% in the past year. This is quite bad
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%

3.2 Future

1FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
1FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1FRE.MI Yearly Revenue VS Estimates1FRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
1FRE.MI Yearly EPS VS Estimates1FRE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.70, 1FRE is valued correctly.
80.00% of the companies in the same industry are more expensive than 1FRE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.03, 1FRE is valued rather cheaply.
A Price/Forward Earnings ratio of 11.03 indicates a reasonable valuation of 1FRE.
Based on the Price/Forward Earnings ratio, 1FRE is valued a bit cheaper than the industry average as 68.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1FRE to the average of the S&P500 Index (36.28), we can say 1FRE is valued rather cheaply.
Industry RankSector Rank
PE 12.7
Fwd PE 11.03
1FRE.MI Price Earnings VS Forward Price Earnings1FRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

1FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, 1FRE is valued a bit more expensive than 64.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.82
EV/EBITDA 9.84
1FRE.MI Per share data1FRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.91%

4

5. Dividend

5.1 Amount

1FRE has a Yearly Dividend Yield of 2.37%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.85, 1FRE pays a bit more dividend than its industry peers.
1FRE's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.37%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1FRE pays out 22.75% of its income as dividend. This is a sustainable payout ratio.
DP22.75%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
1FRE.MI Yearly Income VS Free CF VS Dividend1FRE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
1FRE.MI Dividend Payout.1FRE.MI Dividend Payout, showing the Payout Ratio.1FRE.MI Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

BIT:1FRE (7/18/2025, 7:00:00 PM)

40.89

-2.8 (-6.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners36.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.03B
Analysts83.48
Price Target49.8 (21.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.37%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP22.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.13%
Min EPS beat(2)12.64%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.43%
EPS beat(12)5
Avg EPS beat(12)-43.42%
EPS beat(16)8
Avg EPS beat(16)-32.16%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.4%
Max Revenue beat(2)2.84%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)5
Avg Revenue beat(12)0.35%
Revenue beat(16)7
Avg Revenue beat(16)0.43%
PT rev (1m)2.28%
PT rev (3m)7.91%
EPS NQ rev (1m)7.18%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 12.7
Fwd PE 11.03
P/S 1.04
P/FCF 14.82
P/OCF 9.37
P/B 1.19
P/tB 10.67
EV/EBITDA 9.84
EPS(TTM)3.22
EY7.87%
EPS(NY)3.71
Fwd EY9.06%
FCF(TTM)2.76
FCFY6.75%
OCF(TTM)4.37
OCFY10.68%
SpS39.25
BVpS34.46
TBVpS3.83
PEG (NY)1.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROCE 5.5%
ROIC 4.04%
ROICexc 4.55%
ROICexgc 10%
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
FCFM 7.03%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)2.76%
ROIC(5y)3.92%
ROICexc(3y)2.76%
ROICexc(5y)3.98%
ROICexgc(3y)5.56%
ROICexgc(5y)8.77%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Debt/EBITDA 3.91
Cap/Depr 77.02%
Cap/Sales 4.09%
Interest Coverage 4.28
Cash Conversion 79.5%
Profit Quality 368.25%
Current Ratio 1.43
Quick Ratio 1.11
Altman-Z 1.94
F-Score7
WACC5.21%
ROIC/WACC0.78
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%
EBIT growth 1Y9.47%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y16.02%
FCF growth 1Y-34.12%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-42.44%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%